Xeris Biopharma Holdings, Inc. (XERS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.26B |
| Enterprise Value | 1.19B |
| P/E Ratio | -394.76 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 7.85 |
| Price/Book Ratio | 58.71 |
| Enterprise/Revenue | 8.11 |
| Enterprise/EBITDA | 113.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.02 |
| Operating Margin | 0.13 |
| Return On Assets | -0.02 |
| Return On Equity | -0.4 |
| Revenue | 291.85M |
| Revenue/Share | 2.04 |
| Gross Profit | 238.43M |
| EBITDA | 12.71M |
| Net Income | 554,000 |
| Diluted EPS | 0 |
| Total Cash | 131.08M |
| Total Cash/Share | 0.72 |
| Total Debt | 226.07M |
| Total Debt/Equity | 4.63 |
| Current Ratio | 2.15 |
| Book Value Per Share | 0.27 |
| 52-Week Change | 112.77 |
| 52-Week High | 16.11 |
| 52-Week Low | 5.25 |
| Moving Average 50 Days | 9.92 |
| Moving Average 200 Days | 7.69 |
| Average Volume | 2.72M |
| Shares Outstanding | 182.7M |
| % Held by Institutions | 63.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |